MediPharm Labs's market cap is currently ―. The company's EPS TTM is C$-0.036; its P/E ratio is -2.22; MediPharm Labs is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is C

gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	C$ 8.51M	C$ 9.58M	C$ 5.84M	C$ -16.32M	C$ 7.26M
Gross Profit	C$ 2.42M	C$ 1.44M	C$ 5.84M	C$ -25.50M	C$ -1.19M
EBIT	C$ -4.18M	C$ -2.59M	C$ -3.08M	C$ -23.70M	C$ -7.91M
EBITDA	C$ -4.18M	C$ -1.90M	C$ -2.59M	-	C$ -7.16M
Net Income Common Stockholders	C$ -4.33M	C$ -2.70M	C$ -3.09M	C$ -23.48M	C$ -7.93M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 12.95M	C$ 14.74M	C$ 20.15M	C$ 24.14M	C$ 19.45M
Total Assets	C$ 68.01M	C$ 73.52M	C$ 62.05M	C$ 64.13M	C$ 71.23M
Total Debt	C$ 2.72M	C$ 2.91M	C$ 218.00K	C$ 632.00K	C$ 1.17M
Net Debt	C$ -10.23M	C$ -11.83M	C$ -19.93M	C$ -23.51M	C$ -18.29M
Total Liabilities	C$ 12.80M	C$ 14.51M	C$ 8.39M	C$ 9.49M	C$ 10.76M
Stockholders Equity	C$ 55.20M	C$ 59.01M	C$ 53.66M	C$ 56.01M	C$ 60.48M
Cash Flow	-
Free Cash Flow	-	C$ -7.60M	C$ -3.08M	C$ -477.00K	C$ -3.20M
Operating Cash Flow	-	C$ -7.53M	C$ -3.05M	C$ -168.00K	C$ -2.89M
Investing Cash Flow	-	C$ 946.00K	C$ -25.00K	C$ 5.71M	C$ -316.00K
Financing Cash Flow	-	C$ 1.09M	C$ -919.00K	C$ -399.00K	C$ -143.00K

Currency in CAD

MediPharm Labs Earnings and Revenue History

Income Statement >

MediPharm Labs Debt to Assets

Balance Sheet >

MediPharm Labs Cash Flow

Cash Flow >

MediPharm Labs Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing